LAUER REGAN J — SEC Form 4 filings
SEC reporting owner CIK 1200637. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-24.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-02 to 2026-02-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | Chief Accounting Officer | 7 | — | — | 19 |
Form 4 filings — LAUER REGAN J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-24 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 4,065 @ $0 · Tax withholding (F): 1,673 @ $8.70 · Option exercise (M): 4,065 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 5,482 @ $0 · Tax withholding (F): 2,257 @ $6.93 · Option exercise (M): 5,482 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 4,065 @ $0 · Tax withholding (F): 1,669 @ $3.42 · Option exercise (M): 4,065 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 16,447 (derivative) @ $0 · Grant/award (A): 56,250 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 21,031 @ $0 · Tax withholding (F): 7,503 @ $2.87 · Option exercise (M): 21,031 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | ImmunityBio, Inc. (IBRX) | Grant/award (A): 12,195 (derivative) @ $0 · Grant/award (A): 42,439 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | ImmunityBio, Inc. (IBRX) | Option exercise (M): 32,872 @ $0 · Tax withholding (F): 13,470 @ $3.36 · Option exercise (M): 32,872 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1200637 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →